I-Sleep NDC 55714-2569

NDC codes

FDA NDC Directory

Product NDC (as listed)55714-2569Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55714-2569Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55714-2569-1	55714256901	28 g in 1 BOTTLE, GLASS (55714-2569-1)Marketed from Feb 1, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): I-Sleep
Generic name (nonproprietary): absinthium, anacardium orientale, arg. nit., arsenicum alb., belladonna, bryonia, calc. carb., camphora, chamomilla, cimicifuga, cinchona, coffea cruda, cypripedium, gelsemium, humulus, hyoscyamus, ignatia, kali brom., nux vom., passiflora, pulsatilla, scutellaria lateriflora, sepia, thuja occ., valeriana
Active ingredients: Wormwood — 15 [hp_X]/gSemecarpus anacardium juice — 15 [hp_X]/gSilver nitrate — 15 [hp_X]/gArsenic trioxide — 15 [hp_X]/gAtropa belladonna — 15 [hp_X]/gMatricaria chamomilla — 15 [hp_X]/gBryonia alba root — 15 [hp_X]/gOyster shell calcium carbonate, Crude — 15 [hp_X]/gCamphor (Natural) — 15 [hp_X]/gBlack cohosh — 15 [hp_X]/gCinchona officinalis bark — 15 [hp_X]/gArabica coffee bean — 15 [hp_X]/gCypripedium parviflorum var. Pubescens root — 15 [hp_X]/gGelsemium sempervirens root — 15 [hp_X]/gHops — 15 [hp_X]/gHyoscyamus niger — 15 [hp_X]/gStrychnos ignatii seed — 15 [hp_X]/gPotassium bromide — 15 [hp_X]/gStrychnos nux-vomica seed — 15 [hp_X]/gSepia officinalis juice — 15 [hp_X]/gPassiflora incarnata flowering top — 15 [hp_X]/gAnemone pulsatilla — 15 [hp_X]/gScutellaria lateriflora whole — 15 [hp_X]/gThuja occidentalis leafy twig — 15 [hp_X]/gValerian — 6 [hp_X]/g
Dosage form: Pellet
Route: Oral
Labeler: Newton Laboratories, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Feb 1, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Allergens (Chemical structure)Allergens (Chemical structure)Allergens (Chemical structure)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Dietary Proteins (Chemical structure)Dietary Proteins (Chemical structure)Food Additives (Chemical structure)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased IgG Production (Physiologic effect)Plant Proteins (Chemical structure)Plant Proteins (Chemical structure)Plant Proteins (Chemical structure)Seed Storage Proteins (Chemical structure)Seed Storage Proteins (Chemical structure)
Identifiers: Product ID 55714-2569_c6a0f7de-6eae-1ef8-e053-2995a90ad239SPL ID c6a0f7de-6eae-1ef8-e053-2995a90ad239SPL set ID c6a1163c-b21e-6474-e053-2995a90a1750UNII F84709P2XV, Y0F0BU8RDU, 95IT3W8JZE, S7V92P67HO, WQZ3G9PF0H, G0R4UBI2ZZ, T7J046YI2B, 2E32821G6I, N20HL7Q941, K73E24S6X9, S003A158SB, 3SW678MX72, 21Y9GZ1LZA, 639KR60Q1Q, 01G73H6H83, 4WRK2153H3, 1NM3M2487K, OSD78555ZM, 269XH13919, QDL83WN8C2, CLF5YFS11O, I76KB35JEV, 7BP4DH5PDC, 1NT28V9397, JWF5YAW3QW
Pharmacologic class: Non-Standardized Food Allergenic Extract; Non-Standardized Plant Allergenic Extract

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455714256901 followed by a unit qualifier and the quantity

Package 55714-2569-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 1, 2021.

Indications (excerpt from the label)

INDICATIONS & USAGE SECTION Formulated for symptoms associated with sleeplessness such as frequent waking, restlessness and the inability to fall asleep or return to sleep after waking.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)